Ginkgo Biloba for Dementia

Verdict: Does not prevent dementia; treatment effect disputed

Ginkgo biloba does not prevent dementia or Alzheimer's disease, and the evidence that it meaningfully treats existing dementia is weak and disputed. Major health authorities do not recommend it for memory or cognitive decline.

D 🔴 D Counter-Evidence Disputed

🔬Why this grade7-layer evidence engine

The strongest evidence concerns prevention, and it is squarely negative. The large government-funded GEM trial (PMID 19017911; n=3,069, ~6 years) found ginkgo no better than placebo at preventing dementia (HR 1.12) or Alzheimer's (HR 1.16), and a pooled meta-analysis (PMID 26058281; n=5,889) confirmed no effect (OR 1.05). Because the only high-quality data point in this direction shows the supplement failing, the claim earns a Counter-Evidence (D) grade.

The grade is marked 'disputed' rather than simply ineffective because the picture for treating people who already have dementia is mixed. One meta-analysis (PMID 25114079) reported modest gains in cognition and daily function with standardized EGb 761 at 240 mg/day, but the Cochrane review (PMID 19160216) judged that benefit 'inconsistent and unreliable,' and the positive trials carry potential manufacturer conflicts of interest. Any signal is small, limited to a specific standardized extract, and does not change disease course.

Regulators and clinicians align with the negative read. The NIH's NCCIH states there is 'no conclusive evidence that ginkgo is helpful for any health condition,' the UK NHS warns there is 'not enough evidence' and advises caution, the Cleveland Clinic notes it is 'not intended to... prevent any disease,' and the Alzheimer's Association cites the NIA trial showing ginkgo 'no more effective than a placebo.' Note the meaningful bleeding-risk interaction with blood thinners.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.39
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Disputed
Confidence
80%
Broadly consistent
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.35
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.391
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Ginkgo biloba for prevention of dementia: a randomized controlled trial (GEM Study)
PMID: 19017911 2008 RCT (double-blind) n = 3,069
Finding: Ginkgo did NOT prevent dementia: all-cause dementia HR 1.12 (95% CI 0.94-1.33, p=.21), AD HR 1.16 (95% CI 0.97-1.39, p=.11) over median 6.1 years in adults aged >=75.
🟢 High quality Government Effect size: HR 1.12 all-cause dementia (null)
View on PubMed
Ginkgo biloba for prevention of dementia: a systematic review and meta-analysis
PMID: 26058281 2015 統合分析 n = 5,889
Finding: Pooling 2 RCTs (5,889 participants), no difference in dementia incidence between Ginkgo and placebo (347/2,951 vs 330/2,938; OR 1.05, 95% CI 0.89-1.23); no convincing evidence Ginkgo prevents dementia.
Academic Effect size: OR 1.05 incident dementia (null)
View on PubMed
Ginkgo biloba for cognitive impairment and dementia (Cochrane review, Birks & Grimley Evans)
PMID: 19160216 2009 系統性回顧 n = 2,016
Finding: 36 trials included (9 six-month trials, n=2,016 analysed in detail); more recent trials showed inconsistent results for cognition and ADL; evidence of clinically significant benefit judged inconsistent and unreliable.
🟢 High quality Academic
View on PubMed
Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis (Tan et al.)
PMID: 25114079 2015 統合分析 n = 2,561
Finding: Pooling 9 RCTs (n=2,561), EGb 761 240 mg/day favored over placebo for cognition (WMD -2.86, 95% CI -3.18 to -2.54), ADL (SMD -0.36, 95% CI -0.44 to -0.28) and global change (Peto OR 1.88, 95% CI 1.54-2.29), especially with neuropsychiatric symptoms.
Effect size: Cognition WMD -2.86; ADL SMD -0.36 (favoring EGb 761)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
Most consider the main benefit of Ginkgo biloba to be its ability to prevent the worsening of memory problems due to … neurodegenerative disease. source↗
L4b EU EFSA
Not addressed
Some 'general function' claims (1548 botanical-related claims) have been put on hold pending for the Commission and Member States final consideration. source↗
L4c UK NHS
Cautious
Some people with dementia and their carers use complementary remedies, such as gingko biloba, curcumin or coconut oil. However, there's not enough evidence to say whether such remedies are effective. ... It's best to be wary of any products that claim to benefit people with dementia. If you're thinking of taking such a product or supplement, it's important to consult a doctor first. Some remedi… source↗
L4d TW TFDA / 衛福部
Cautious
銀杏果(俗稱白果)屬於一般食品,並無療效。而銀杏葉萃取物,在我國是以藥品管理。其效果僅限於改善末梢血液循環,對於老年失智、中風及動脈血管疾病,並未證實有治療效果。 source↗
L4e WHO
Neutral
WHO monographs on selected medicinal plants - Volume 1 source↗
L5a NIH Office of Dietary Supplements
Cautious
There's no conclusive evidence that ginkgo is helpful for any health condition. source↗
L5c Cleveland Clinic
Cautious
This supplement is not intended to diagnose, treat, cure, or prevent any disease. source↗
L5e Specialty Society (condition-mapped)
Against
A study funded by the National Institute on Aging (NIA) of more than 3,000 older volunteers found that ginkgo biloba was no more effective than a placebo in preventing or delaying Alzheimer's or other dementia. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-dementia-INT-ginkgo-biloba-001 繁體中文版 →